Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

BMI curve for LSES. حسب Krystal Hunter (6820052)

الموضوعات:

BMI groups by SES. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part2. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for HSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for overall population. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part1. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات:

Diagram of study population. حسب Krystal Hunter (6820052)

الموضوعات:

PLB is a target gene of miRNA 221. حسب Hongyu Li (1332669)

The heart rate was similar among the groups. حسب Hongyu Li (1332669)

"…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…"

S1 File - حسب Hongyu Li (1332669)

"…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…"